Liabilities / Assets
99th percentile
Higher debt load relative to assets than 99% of similar nonprofits.
990EZ • Fiscal year 2017 • EIN 82-1199380
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
99th percentile
Higher debt load relative to assets than 99% of similar nonprofits.
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on this filing.
Net Margin
Score unavailable
Net margin requires both revenue and expenses on this filing.
Top Officer Pay
76th percentile
Higher top officer pay than 76% of similar nonprofits.
Asset Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Assets
$44,119
No earlier filing loaded for comparison.
Net Assets
-$105,881
No earlier filing loaded for comparison.
Liabilities
$300,000
No earlier filing loaded for comparison.
Revenue
$0
No earlier filing loaded for comparison.
Expenses
$105,881
No earlier filing loaded for comparison.
Net Income
-$105,881
No earlier filing loaded for comparison.
Our mission is to lead the development and ongoing management of clinical trial platforms to accelerate the discovery and development of cures for patients with rare and deadly diseases.
1)to provide grants, funds, aid and assistance to scientific and medical institutes, scientists and physicians engaged in medical and scientific research as to the causes of, prevention of, iearly diagnosis of, and treatment of cancers of all types; 2)to promote and support the use of cancer-specific platform trials of new drugs and other treatments of cancer so that multiple treatment modalities may be tested and evaluated simultaneously; ongoing clinical trials may be continuously updated to incorporate the latest clinical trial research results; and the most effective treatment protocols for various types of cancer may be developed and approved sooner; 3)to promote and support financially and otherwise, public education as to the use of cancer-specific platform trials that result in protocols that may lead to earlier diagnosis and treatment of cancers of all types; 4)to underwrite, sponsor, and support academic and scholarly studies, symposia, curricula development, research, semina
| Description | Grants | Expenses |
|---|---|---|
| N/A | - | - |
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| BRIAN M ALEXANDER | President | - | $0 | - | - |
| SUJUAN BA | Secretary | - | $0 | - | - |
| WEBSTER CAVENCE | Officer | - | $0 | - | - |
| TIMOTHY F CLOUGHESY | Officer | - | $0 | - | - |
“Expenses advertising and promotion 15,453 office 3,393 travel 4,989 insurance 3,477 total 27,312”
“Unsecured notes and loans payable 0 150,000 loans from officers 0 150,000”
“1)to provide grants, funds, aid and assistance to scientific and medical institutes, scientists and physicians engaged in medical and scientific research as to the causes of, prevention of, iearly diagnosis of, and treatment of cancers of all types; 2)to promote and support the use of cancer-specific platform trials of new drugs and other treatments of cancer so that multiple treatment modalities may be tested and evaluated simultaneously; ongoing clinical trials may be continuously updated to incorporate the latest clinical trial research results; and the most effective treatment protocols for various types of cancer may be developed and approved sooner; 3)to promote and support financially and otherwise, public education as to the use of cancer-specific platform trials that result in protocols that may lead to earlier diagnosis and treatment of cancers of all types; 4)to underwrite, sponsor, and support academic and scholarly studies, symposia, curricula development, research, seminars, and presentations as to the topics set forth above in governmental institutions, in the media and in schools, colleges, universities and other educational institutions throughout the united states and abroad; 5)to encourage state and federal government agencies to provide adequate funding to promote the use of cancer-specific platform trials that can lead to more efficacious treatments of cancer and the ability of cancer patients to avail themselves of such treatments sooner than previously possible via standard clinical trial protocols. 6)to accomplish the above purposes by all reasonable and practical means, including the publication and dissemination of information in all forms and through all media, to the public in the united states and in foreign states; and 7)to engage in any lawful acts and enter into all lawful agreements that may be necessary, useful, suitable or proper to accomplish the charitable purposes of the corporation, provided the same is permitted under section 501(c)(3) of the code.”
“The organization amended its articles of incorporation to change its name. A copy of the articles of amenndment was previously submitted to the irs on december 22, 2017.”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | BRIAN M ALEXANDER |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 6172996471 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 128 KENDALL ROAD |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | LEXINGTON |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | MA |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 02421 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 44119 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | true |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | -105881 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 78569 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 0 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 44119 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartVInd | 0 | X |
| IRS990EZ/InitialReturnInd | 0 | X |
| IRS990EZ/LoansToFromOfficersAmt | 0 | 150000 |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | true |
| IRS990EZ/MethodOfAccountingCashInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | -105881 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 0 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | -255881 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 000.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 000.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 000.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 000.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | BRIAN M ALEXANDER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | SUJUAN BA |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | WEBSTER CAVENCE |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | TIMOTHY F CLOUGHESY |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | PRESIDENT |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | SECRETARY |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | OFFICER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | OFFICER |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 27312 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | 1)TO PROVIDE GRANTS, FUNDS, AID AND ASSISTANCE TO SCIENTIFIC AND MEDICAL INSTITUTES, SCIENTISTS AND PHYSICIANS ENGAGED IN MEDICAL AND SCIENTIFIC RESEARCH AS TO THE CAUSES OF, PREVENTION OF, IEARLY DIAGNOSIS OF, AND TREATMENT OF CANCERS OF ALL TYPES; 2)TO PROMOTE AND SUPPORT THE USE OF CANCER-SPECIFIC PLATFORM TRIALS OF NEW DRUGS AND OTHER TREATMENTS OF CANCER SO THAT MULTIPLE TREATMENT MODALITIES MAY BE TESTED AND EVALUATED SIMULTANEOUSLY; ONGOING CLINICAL TRIALS MAY BE CONTINUOUSLY UPDATED TO INCORPORATE THE LATEST CLINICAL TRIAL RESEARCH RESULTS; AND THE MOST EFFECTIVE TREATMENT PROTOCOLS FOR VARIOUS TYPES OF CANCER MAY BE DEVELOPED AND APPROVED SOONER; 3)TO PROMOTE AND SUPPORT FINANCIALLY AND OTHERWISE, PUBLIC EDUCATION AS TO THE USE OF CANCER-SPECIFIC PLATFORM TRIALS THAT RESULT IN PROTOCOLS THAT MAY LEAD TO EARLIER DIAGNOSIS AND TREATMENT OF CANCERS OF ALL TYPES; 4)TO UNDERWRITE, SPONSOR, AND SUPPORT ACADEMIC AND SCHOLARLY STUDIES, SYMPOSIA, CURRICULA DEVELOPMENT, RESEARCH, SEMINA |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | N/A |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/ScheduleBNotRequiredInd | 0 | X |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt | 0 | 300000 |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 105881 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | N/A |
| IRS990ScheduleA/First5Years509Ind | 0 | X |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt | 0 | 1 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 1 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 1 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 1 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 1 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 1 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 1 |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt | 0 | 150000 |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd | 0 | true |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BusinessName/BusinessNameLine1Txt | 0 | NOTE PAYABLE |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BusinessName/BusinessNameLine2Txt | 0 | WINDMILL REALTY ADVISORS INC |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd | 0 | false |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt | 0 | WORKING CAPITAL |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd | 0 | X |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt | 0 | 150000 |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt | 0 | RELATED TO DIRECTOR |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd | 0 | true |
| IRS990ScheduleL/TotalBalanceDueAmt | 0 | 150000 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | EXPENSES ADVERTISING AND PROMOTION 15,453 OFFICE 3,393 TRAVEL 4,989 INSURANCE 3,477 TOTAL 27,312 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | UNSECURED NOTES AND LOANS PAYABLE 0 150,000 LOANS FROM OFFICERS 0 150,000 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | 1)TO PROVIDE GRANTS, FUNDS, AID AND ASSISTANCE TO SCIENTIFIC AND MEDICAL INSTITUTES, SCIENTISTS AND PHYSICIANS ENGAGED IN MEDICAL AND SCIENTIFIC RESEARCH AS TO THE CAUSES OF, PREVENTION OF, IEARLY DIAGNOSIS OF, AND TREATMENT OF CANCERS OF ALL TYPES; 2)TO PROMOTE AND SUPPORT THE USE OF CANCER-SPECIFIC PLATFORM TRIALS OF NEW DRUGS AND OTHER TREATMENTS OF CANCER SO THAT MULTIPLE TREATMENT MODALITIES MAY BE TESTED AND EVALUATED SIMULTANEOUSLY; ONGOING CLINICAL TRIALS MAY BE CONTINUOUSLY UPDATED TO INCORPORATE THE LATEST CLINICAL TRIAL RESEARCH RESULTS; AND THE MOST EFFECTIVE TREATMENT PROTOCOLS FOR VARIOUS TYPES OF CANCER MAY BE DEVELOPED AND APPROVED SOONER; 3)TO PROMOTE AND SUPPORT FINANCIALLY AND OTHERWISE, PUBLIC EDUCATION AS TO THE USE OF CANCER-SPECIFIC PLATFORM TRIALS THAT RESULT IN PROTOCOLS THAT MAY LEAD TO EARLIER DIAGNOSIS AND TREATMENT OF CANCERS OF ALL TYPES; 4)TO UNDERWRITE, SPONSOR, AND SUPPORT ACADEMIC AND SCHOLARLY STUDIES, SYMPOSIA, CURRICULA DEVELOPMENT, RESEARCH, SEMINARS, AND PRESENTATIONS AS TO THE TOPICS SET FORTH ABOVE IN GOVERNMENTAL INSTITUTIONS, IN THE MEDIA AND IN SCHOOLS, COLLEGES, UNIVERSITIES AND OTHER EDUCATIONAL INSTITUTIONS THROUGHOUT THE UNITED STATES AND ABROAD; 5)TO ENCOURAGE STATE AND FEDERAL GOVERNMENT AGENCIES TO PROVIDE ADEQUATE FUNDING TO PROMOTE THE USE OF CANCER-SPECIFIC PLATFORM TRIALS THAT CAN LEAD TO MORE EFFICACIOUS TREATMENTS OF CANCER AND THE ABILITY OF CANCER PATIENTS TO AVAIL THEMSELVES OF SUCH TREATMENTS SOONER THAN PREVIOUSLY POSSIBLE VIA STANDARD CLINICAL TRIAL PROTOCOLS. 6)TO ACCOMPLISH THE ABOVE PURPOSES BY ALL REASONABLE AND PRACTICAL MEANS, INCLUDING THE PUBLICATION AND DISSEMINATION OF INFORMATION IN ALL FORMS AND THROUGH ALL MEDIA, TO THE PUBLIC IN THE UNITED STATES AND IN FOREIGN STATES; AND 7)TO ENGAGE IN ANY LAWFUL ACTS AND ENTER INTO ALL LAWFUL AGREEMENTS THAT MAY BE NECESSARY, USEFUL, SUITABLE OR PROPER TO ACCOMPLISH THE CHARITABLE PURPOSES OF THE CORPORATION, PROVIDED THE SAME IS PERMITTED UNDER SECTION 501(C)(3) OF THE CODE. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | THE ORGANIZATION AMENDED ITS ARTICLES OF INCORPORATION TO CHANGE ITS NAME. A COPY OF THE ARTICLES OF AMENNDMENT WAS PREVIOUSLY SUBMITTED TO THE IRS ON DECEMBER 22, 2017. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART II, LINE 26 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990-EZ, PART V, LINE 34 |
| ReturnHeader/BuildTS | 0 | 2018-06-14 16:35:46Z |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | BRIAN M ALEXANDER |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | PRESIDENT |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 6172996471 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2018-05-15 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | GLOBAL COALITION FOR ADAPTIVE |
| ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt | 0 | RESEARCH INC |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | GLOB |
| ReturnHeader/Filer/EIN | 0 | 821199380 |
| ReturnHeader/Filer/PhoneNum | 0 | 6172996471 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 1661 MASSACHUSETTS AVENUE BOX 427 |
| ReturnHeader/Filer/USAddress/CityNm | 0 | LEXINGTON |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | MA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 024209998 |
| ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId | 0 | 502207283B69E2554CFB007E8895A735A19BDCEA |
| ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId | 0 | 502207283B69E2554CFB007E8895A735A19BDCEA |
| ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd | 0 | P |
| ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt | 0 | 65.200.43.29 |
| ReturnHeader/FilingSecurityInformation/IPDt | 0 | 2018-05-15 |
| ReturnHeader/FilingSecurityInformation/IPTimezoneCd | 0 | CD |
| ReturnHeader/FilingSecurityInformation/IPTm | 0 | 19:31:05 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 274279115 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | BARLOW DOUGLAS & HALL CPAS PLLC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 1671 W HORIZON RIDGE PKWY STE 220 |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | HENDERSON |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | NV |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 890123523 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 7022022255 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2018-05-15 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | DEAN L WALKER CPA |
| ReturnHeader/ReturnTs | 0 | 2018-05-15T20:31:05-04:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2017-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2017-12-31 |
| ReturnHeader/TaxYr | 0 | 2017 |
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990EZDetailed filing. Detailed filing data is available for this year.